The role of candida surveillance cultures for identification of a preterm subpopulation at highest risk for invasive fungal infection

Pediatric Infectious Disease Journal

Volumn 27, Issue 12, 2008, Pages 1114-1116

  Vendettuoli, Valentina ^a   Tana, Milena ^a   Tirone, Chiara ^a   Posteraro, Brunella ^b   La Sorda, Marilena ^b   Fadda, Giovanni ^b   Romagnoli, Costantino ^a   Vento, Giovanni ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Candida; fungal colonization; very low birth weight neonates

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCYTOSINE; ANTIFUNGAL AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; CANDIDA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; EVALUATION; FUNGAL COLONIZATION; FUNGUS CULTURE; GESTATIONAL AGE; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INVASIVE CANDIDIASIS; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; PATIENT IDENTIFICATION; PREMATURITY; PRIORITY JOURNAL; SCREENING TEST; VERY LOW BIRTH WEIGHT; CANDIDIASIS; CASE CONTROL STUDY; INFANT; ISOLATION AND PURIFICATION; MORTALITY; NEWBORN SCREENING; NONPARAMETRIC TEST; RISK FACTOR;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CASE-CONTROL STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; NEONATAL SCREENING; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 58149381664     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31817fce78     Document Type: Article

References (14)

1. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285-291.
2. Saiman L, Ludington E, Dawson JD, et al. Risk factors for candidemia in neonatal intensive care unit patients: the National Epidemiology of Mycosis Survey Sudy Protocol. Pediatr Infect Dis J. 2000;19:319-324.
3. Kaufman D. Strategies for prevention of neonatal invasive candidiasis. Semin Perinatol. 2003;27:414-424.
4. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345:1660-1666.
5. Manzoni P, Stol? I, Pugni L, et al. A multicenter, randomized trial of prophylactic ?uconazole in preterm neonates. N Engl J Med. 2007;356: 2483-2495.
6. Perea S, Patterson TF. Antifungal resistance in pathogenic fungi. Clin Infect Dis. 2002;35:1073-1080.
7. Healy CM, Baker CZ, Zaccaria E, et al. Impact of ?uconazole prophy- laxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr. 2005;147:166-171.
8. Muñoz P, Burillo A, Bouza E. Criteria used when initiating antifungal therapy against Candida spp in the intensive care unit. Int J Antimicrob Agents. 2000;15:83-90.
9. Ascioglu S, Rex JH, de Pauw B, et al. De?ning opportunistic invasive fungal infection in immunocompromised patients with cancer and he- matopoietic stem cell transplants: an international consensus. Clinic Infect Dis. 2002;34:7-14.
10. Manzoni P, Pedicino R, Stol? I, et al. Criteria for the diagnosis of systemic fungal infections in newborns: a report from the Task Force on neonatal fungal infections of the GSIN. Pediatr Med Chir. 2004;26: 89-95 -article in Italian-.
11. National Nosocomial Infection Surwey Manual. Available at: http://www. cdc.gov/ncidod/dhqp/pdf/nhsn/NHSN-Manual-PatientSafetyProtocol-CURRENT.pdf.
12. Rosenberg MB, Garb JL, Fisher DJ, et al. Early onset Candida infection in the neonate: risks and trends. Pediatr Res. 2004;55:406A.
13. Warren NG, Hazen KC. Candida, Cryptococcus, and other yeasts of medical importance. In: Murray RP, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:1184-1199.
14. Rowen JL, Rench MA, Kozinetz CA, et al. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr. 1994;124:789-794.